BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17443733)

  • 21. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
    Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
    J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parapharyngeal lymph node involvement in papillary thyroid carcinoma.
    Ortapamuk H; Arican P; Alp A
    Clin Nucl Med; 2003 Nov; 28(11):947-8. PubMed ID: 14578722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
    Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Castleman disease mimicking nodal recurrence of thyroid cancer.
    Zeng YH; Chen CK; Lee CC
    Endocrine; 2016 Feb; 51(2):384-6. PubMed ID: 26054905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer.
    Low TH; Delbridge L; Sidhu S; Learoyd D; Robinson B; Roach P; Sywak M
    Ann Surg Oncol; 2008 Oct; 15(10):2827-32. PubMed ID: 18636294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radio-guided surgery for non-131I-avid thyroid cancer.
    Rubello D; Pelizzo MR; Casara D; Piotto A; Toniato A; Fig L; Gross M
    Thyroid; 2006 Nov; 16(11):1105-11. PubMed ID: 17123337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Limited radical approach in differentiated thyroid gland cancers. A prospective study of 107 patients].
    Engel U; Kucharski A; Zornig C
    Chirurg; 1994 Dec; 65(12):1095-8; discussion 1098-9. PubMed ID: 7851141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hook needle-guided excision of recurrent differentiated thyroid cancer in previously operated neck compartments: a safe technique for small, nonpalpable recurrent disease.
    Triponez F; Poder L; Zarnegar R; Goldstein R; Roayaie K; Feldstein V; Lee J; Kebebew E; Duh QY; Clark OH
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4943-7. PubMed ID: 16968803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new radioguided procedure for localization and surgical treatment of neck node metastasis of papillary thyroid cancer.
    Martino A; Monaco L; Golia R; Miletto P; Capasso P; Lombardi C; De Chiara G; Iannace C; Basagni C; Caracciolo F
    J Endocrinol Invest; 2010 May; 33(5):339-42. PubMed ID: 20061783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous metastatic papillary thyroid carcinoma and carcinoid of the small intestine in the cervical lymph node group.
    Markou KD; Goudakos JK; Triaridis S; Televantou D; Hytiroglou P; Nikolaou A
    Thyroid; 2010 Sep; 20(9):1025-8. PubMed ID: 20718681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of surgical gamma probe for the detection of lymph node metastases in differentiated thyroid cancer.
    Lippi F; Capezzone M; Miccoli P; Traino C; Di Martino F; Angelini F; Spinelli C; Iacconi P; Pinchera A; Pacini F
    Tumori; 2000; 86(4):367-9. PubMed ID: 11016732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Whether VI region lymph nodes belong to primary site of the thyroid carcinoma or lateral cervical lymph node metastases].
    Zhu YX; Wang HS; Wu Y; Ji QH; Huang CP
    Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(14):867-9. PubMed ID: 15363278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Terris DJ
    Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
    Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
    Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
    Travagli JP; Cailleux AF; Ricard M; Baudin E; Caillou B; Parmentier C; Schlumberger M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2675-80. PubMed ID: 9709930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axillary lymph node metastasis in recurrence of papillary thyroid carcinoma: a case report.
    Ers V; Galant C; Malaise J; Rahier J; Daumerie C
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):124-7. PubMed ID: 16703258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papillary microcarcinoma of the thyroid.
    Shaha AR; Tuttle RM; Shah JP
    J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
    [No Abstract]   [Full Text] [Related]  

  • 39. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
    Yunusa GH; Kotze T; Brink A
    Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland.
    Hamming JF; van de Velde CJ; Goslings BM; Fleuren GJ; Hermans J; Delemarre JF; van Slooten EA
    Surg Gynecol Obstet; 1989 Aug; 169(2):107-14. PubMed ID: 2667172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.